CBR-470-2, a glycine-substituted analog, can activate NRF2 signaling. CBR-470-2 can be used for the research of modulation glycolysis.
体外研究
CBR-470-2 (1-10 μM; 24 h) increases transcript levels of the NRF2-responsive genes NQO1 and HMOX1 in epidermal keratinocytes and dermal fibroblasts.
体内研究
CBR-470-2 (50 mg/kg; p.o. twice daily for 10 d) induces activation of NRF2 signaling in vivo.
Animal Model:
Balb/C mice (5-week old) are exposed to UVB
Dosage:
50 mg/kg
Administration:
P.o. twice daily for 10 days
Result:
Resulted in comparable beneficial effects on erythema histological scores and total wounded area.
Decreased epidermal thickness in response to UV exposure.
分子量
402.27
CAS号
2416095-00-4
运输条件
Room temperature in continental US; may vary elsewhere.